Watch a pond light up with glowing alligator eyes. There's so many of them, and they're bellowing ferociously.

Q1 2025 Management View CEO Robert Mauch highlighted strong Q1 performance with 13% revenue growth and a 14% increase in adjusted EPS. He attributed this success to robust execution in the U.S.

Cencora posted Q1 sales of $81.5 billion, exceeding forecasts, with strong GLP-1 drug sales. Adjusted EPS beat estimates, and ...

AI-based analysis is crucial for in-home monitoring, as the high volume of daily patient images is too large for manual ...

Get the current model iPad with the A14 Bionic processor, Wi-Fi 6 connectivity, and Liquid Retina screen for 20% off.

With today’s Amazon “Deals of the Day,” you can save another $50 on the Ring Wired Doorbell Pro video doorbell and the Fire ...

Reports Q1 revenue $81.5B, consensus $78.22B. “Cencora (COR) delivered an excellent start to fiscal 2025 as we focused on advancing our core ...

Drug distributor Cencora raised its fiscal 2025 profit forecast on Wednesday, driven by robust demand for expensive specialty medicines.

This prospective case-control study included 85 patients with lung involvement related to the COVID-19 virus and a group of ...

If your work setup needs a refresh and you're a MacBook user, you'll love this latest deal on the Apple Studio Display. As of ...

McKesson said it will acquire an 80% interest in the provider of general ophthalmology and retina management services. PRISM ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...